Derman Antifungal Liquid Spray

Manufacturer
Taisho Pharmaceutical California Inc.
Effective date
2024-05-30
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 20:53:51

Label at a glance#

ProductDerman Antifungal
Active ingredientTOLNAFTATE
Label structure7 sections

Indications and uses

Clinically proven to prevent most athlete’s foot.  prevent the recurrence of athlete's foot with daily use for effective relief of itching, cracking and burning

Dosage and administration

wash affected area and dry thoroughly shake can well and spray a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes, wear well-fitting, ventilated shoes, and change shoes and socks at least once daily for athlete's foot and ringworm, use daily for 4...

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate 1%

Purpose

OTC - PURPOSE SECTION

Antifungal

Uses

INDICATIONS & USAGE SECTION

  • Clinically proven to prevent most athlete’s foot. 
  • prevent the recurrence of athlete's foot with daily use
  • for effective relief of itching, cracking and burning

Warnings

WARNINGS SECTION

For external use only

Flammable: Contents under pressure. Avoid spraying in eyes. Do not use or store near heat or open flame. Do not puncture or incinerate container. Do not store at temperature above 120ºF. Keep out of the reach of children. Use only as directed. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes or mouth 
  • use only as directed

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation occurs
  • no improvement within four weeks for athlete's foot and ringworm

Do not use

OTC - DO NOT USE SECTION

on children under 2 years of age unless directed by a doctor.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wash affected area and dry thoroughly
  • shake can well and spray a thin layer of the product over affected area
  • twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product
  • for athlete's foot: pay special attention to spaces between the toes, wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
  • for athlete's foot and ringworm, use daily for 4 weeks
  • if condition persists, consult a doctor
  • to prevent athlete's foot: wash the feet and dry thoroughly; spray a thin layer of the product to the feet once or twice daily (morning and/or night)
  • this product is not effective on the scalp or nails
  • if nozzle clogs, clean with a pin

Other information

SPL UNCLASSIFIED SECTION

store between 20° and 30°C (68° and 86°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

BHT, isobutane, PPG-12-buteth-16, SD alcohol 40-B

Package Labeling:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

bottlebottle

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
81929-00681929-006-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2d7c7af8-c587-99cf-e063-6294a90a88a3753ea45a-84e1-4fcd-8ae0-33af3c0a1c852025-02-06WarningsExact identifier
spl set id: 753ea45a-84e1-4fcd-8ae0-33af3c0a1c85

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.